H

HOOKIPA Pharma

D
HOOK
USD
-0.05
(-1.3405%)
Market Closed
22,181.00
Volume
-3.33
EPS
-
Div Yield
-0.893204
P/E
36,413,500.64
Market Cap
Today
-1.3405%
1 Week
-2.646%
1 Month
-8.458%
6 Months
-56.190%
12 Months
-20.655%
Year To Date
-54.708%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
NKE
NKE
0.63
(0.8368%)
USD
S
SPWH
-0.105
(-3.8961%)
USD
D
DKS
4.92
(2.5222%)
USD
F
FL
0.29
(1.1803%)
USD
WMT
WMT
0.41
(0.4914%)
USD
TGT
TGT
3.67
(2.4913%)
USD
COST
COST
14.82
(1.6479%)
USD
AMZN
AMZN
3.02
(1.4575%)
USD

Title:
HOOKIPA Pharma Inc.

Sector:
Healthcare
Industry:
Biotechnology
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Do you need help or have a question?
Contact Us